ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
21.411,53
0,72%
S&P 500
6.118,71
0,53%
Dow Jones
44.565,07
0,92%
Euro vs US Dollar
1,04165
0,08%
Bitcoin
103.084,40
-0,53%
Pepperstone
Advertisement
Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Tandem Diabetes Care Inc (TNDM)

  7. Tandem Diabetes Care Inc (TNDM) News

TNDM

Tandem Diabetes Care (TNDM)

Tandem Diabetes Care Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:TNDM
DatumZeitQuelleÜberschriftSymbolFirma
15/01/202522h05Business WireTandem Diabetes Care to Announce Fourth Quarter and Full Year 2024 Financial Results on February 26, 2025NASDAQ:TNDMTandem Diabetes Care Inc
07/01/202515h00Business WireTandem Diabetes Care Enters Multi-Year Research Collaboration with UVA Center for Diabetes Technology for Development of Advanced Insulin Delivery SystemsNASDAQ:TNDMTandem Diabetes Care Inc
18/12/202422h57Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TNDMTandem Diabetes Care Inc
18/12/202422h56Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TNDMTandem Diabetes Care Inc
10/12/202415h00Business WireLa pompe à insuline Tandem t:slim X2 est désormais compatible avec la SGC Dexcom G7 au CanadaNASDAQ:TNDMTandem Diabetes Care Inc
10/12/202415h00Business WireTandem t:slim X2 Insulin Pump Now Compatible with Dexcom G7 CGM in CanadaNASDAQ:TNDMTandem Diabetes Care Inc
21/11/202422h05Business WireTandem Diabetes Care Announces Upcoming Conference PresentationsNASDAQ:TNDMTandem Diabetes Care Inc
19/11/202423h23Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TNDMTandem Diabetes Care Inc
19/11/202423h23Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TNDMTandem Diabetes Care Inc
19/11/202423h22Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TNDMTandem Diabetes Care Inc
19/11/202423h22Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TNDMTandem Diabetes Care Inc
19/11/202423h22Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TNDMTandem Diabetes Care Inc
19/11/202423h22Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TNDMTandem Diabetes Care Inc
08/11/202423h31Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:TNDMTandem Diabetes Care Inc
06/11/202422h11Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TNDMTandem Diabetes Care Inc
06/11/202422h08Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TNDMTandem Diabetes Care Inc
06/11/202422h05Business WireTandem Diabetes Care Announces Third Quarter 2024 Financial Results and Increases Full Year 2024 Sales GuidanceNASDAQ:TNDMTandem Diabetes Care Inc
30/10/202421h05Business WireTandem Diabetes Care Announces Upcoming Conference ParticipationNASDAQ:TNDMTandem Diabetes Care Inc
02/10/202422h05Business WireTandem Diabetes Care to Announce Third Quarter 2024 Financial Results on November 6, 2024NASDAQ:TNDMTandem Diabetes Care Inc
19/09/202415h00Business WireTandem t:slim X2 Insulin Pump Now Compatible with Lyumjev Ultra-rapid Acting Insulin in European UnionNASDAQ:TNDMTandem Diabetes Care Inc
18/09/202423h06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TNDMTandem Diabetes Care Inc
26/08/202422h05Business WireTandem Diabetes Care Announces Upcoming Conference ParticipationNASDAQ:TNDMTandem Diabetes Care Inc
20/08/202402h31Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TNDMTandem Diabetes Care Inc
20/08/202402h31Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TNDMTandem Diabetes Care Inc
20/08/202402h31Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TNDMTandem Diabetes Care Inc
20/08/202402h31Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TNDMTandem Diabetes Care Inc
20/08/202402h31Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TNDMTandem Diabetes Care Inc
20/08/202400h30Business WireTandem Diabetes Care to Release Updated iOS t:connect Mobile App for t:slim X2 Insulin Pump Users Impacted by March 2024 Nationwide RecallNASDAQ:TNDMTandem Diabetes Care Inc
12/08/202422h30Business WireTandem Diabetes Care Provides Update on March 2024 Nationwide Recall of t:connect Mobile App for iOS DevicesNASDAQ:TNDMTandem Diabetes Care Inc
09/08/202422h52Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TNDMTandem Diabetes Care Inc
 Showing the most relevant articles for your search:NASDAQ:TNDM

Kürzlich von Ihnen besucht

NYSE
HTD
John Hancock Tax Advanta...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2025 ADVFN PLC - Alle Rechte vorbehalten